William A. Magioncalda

A selection of Mr. Magioncalda’s recent representations include:

Initial Public Offerings and Follow-on Offerings

• The underwriters in Royalty Pharma plc’s $2.5 billion initial public offering
• Moderna, Inc. in its $1.34 billion and $500 million public follow-on offering
• The underwriters in Repare Therapeutics, Inc.’s $253 million initial public offering
• HOOKIPA Pharma, Inc. in its $84 million initial public offering
• Goldman Sachs & Co. and other underwriters in Arvinas, Inc.’s $120 million initial public offering and $150 million follow-on offering
• The underwriters in Immunomedics, Inc.’s $420 million and $285 million public follow-on offerings
• The underwriters in Krystal Biotech, Inc.’s $125 million public follow-on offering
• The underwriters in Centogene N.V.’s $56 million initial public offering

Other Corporate Transactions

• Foundation Medicine, Inc. in connection with its merger with Roche at an enterprise valuation of $5.3 billion
• Cowen as sales agent in ATM facilities for Albireo Pharma, Ovid Therapeutics and Dynavax Technologies
• Piper Sandler as sales agent in multiple ATM facilities
• Akili Interactive Labs, Inc. in its $55 million Series C financing
• Even Financial, Inc. in its $25 million Series B financing and $18 million Series A financing
• Aircall.io, Inc. in its $29 million Series B financing